Table 1.
Anthropometric measurements and fasting plasma concentrations taken after 4 weeks daily supplementation with either 40 g/day of HAM-RS2 or placebo.
Figure 1.
Glucose concentrations from FSIVGTT after 4 weeks daily supplementation with 40 g HAM-RS2 or placebo.
N = 12, mean ± SEM. No significant difference between the HAM-RS2 and placebo. Comparisons made with repeated measures ANOVA. Black circles = HAM-RS2; white circles = placebo; dashed line = baseline glucose concentrations.
Figure 2.
Insulin concentrations from FSIVGTT after 4 weeks daily supplementation with 40 g HAM-RS2 or placebo.
N = 12, mean ± SEM. Significantly higher concentrations following HAM-RS2 compared with placebo (p = 0.009). Comparisons made with repeated measures ANOVA. Black circles = HAM-RS2; white circles = placebo.
Figure 3.
C-peptide concentrations from FSIVGTT after 4 weeks daily supplementation with 40 g HAM-RS2 or placebo.
N = 12, mean ± SEM. Significantly higher concentrations following HAM-RS2 compared with placebo (p = 0.016). Comparisons made with repeated measures ANOVA. Black circles = HAM-RS2; white circles = placebo.
Table 2.
Indices from the modelling of the data from the IVGTT.